Mode
Text Size
Log in / Sign up
N/A N=330 Randomized Single-blind Prevention

PRIDE: Preventing Respiratory Illnesses During Childhood Study

Tobacco Smoke Pollution

Enrolled (actual)
330
Serious AEs
0.6%
Results posted
Aug 2017
Primary outcome: Primary: Air Nicotine Levels — 1.17; 0.58; 0.71; 0.51 mg/m^3

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Motivational Interviewing Intervention for ETS Reduction (Behavioral); Educational Program for ETS Reduction (Behavioral)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
Johns Hopkins University
Primary completion
Jan 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Air Nicotine Levels
1.17; 0.58; 0.71; 0.51; 0.75; 0.52
SECONDARY
ETS Reduction, as Measured by Child's Cotinine Levels
4.14; 3.00; 4.14; 3.25; 3.60; 3.04
SECONDARY
Respiratory Function of Child by Self Report of Parent
1.07; 1; 0.44; 0.54; 0.38; 0.36
SECONDARY
Health Care Utilization by Child- Self Report From Parent/Caregiver
80; 73; 18; 15; 14; 19
SECONDARY
Number of Participants Who Report Endorsing a Home Smoking Ban
129; 118; 80; 89; 78; 83

Summary

Environmental tobacco smoke (ETS0, also known as secondhand smoke, is the combination of smoke given off by the burning end of a tobacco product and the smoke exhaled by the smoker. Children exposed to ETS are at an increased risk of sudden infant death syndrome (SIDS), ear infections, colds, pneumonia, bronchitis and more severe asthma. ETS can also slow the growth of children's lungs and can cause them to cough, wheeze and fell breathless. The purpose of this study is to determine the effectiveness of a motivational interviewing-based program in reducing ETS exposure and improving lung health among children who are enrolled in a Head Start program and whose households include a smoker.

Eligibility Criteria

Inclusion Criteria

  • Child enrolled in Baltimore City Head Start
  • Smoker living in the home with child

Exclusion Criteria

  • No smoker in home with child
  • Does not speak English
  • Is enrolled in other respiratory research study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00927264). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search